The New York Times Trends

The makers of the Pfizer-BioNTech Covid vaccine will soon ask regulators to approve its use in children 5 years and over, and are getting ready to make smaller doses of the vaccine for younger children, according to a BioNTech founder. https://t.co/ny30QkvsDC https://t.co/VqOMLSoLZZ